Therapeutic apheresis
Showing 1 - 25 of >10,000
Vascular Access Complications for Therapeutic Apheresis in
Recruiting
- Vascular Access Complication
- Apheresis Related Complication
-
Nancy, FranceCentral Hospital
May 30, 2023
Tolerance of Therapeutic Apheresis in Paediatric
Completed
- Apheresis Related Complication
- Efficacy of apheresis
-
Montpellier, FranceUh Montpellier
Apr 11, 2022
Stroke, Ischemic Trial in Ulm (CRP apheresis)
Recruiting
- Stroke, Ischemic
- CRP apheresis
-
Ulm, Bayern, GermanyAbteilung für Neurologie, Universität Ulm
Mar 8, 2022
Stroke, Ischemic Trial in Berlin (CRP apheresis)
Recruiting
- Stroke, Ischemic
- CRP apheresis
-
Berlin, GermanyZentrum für Schlaganfallforschung (CSB) / Klinik für Neurologie
Mar 24, 2022
Sepsis, Respiratory Failure Trial in Germany, Switzerland, United Kingdom (NucleoCapture device)
Not yet recruiting
- Sepsis
- Respiratory Failure
- NucleoCapture device
-
Bonn, Germany
- +8 more
Dec 12, 2022
Post-cardiac Surgery Trial in Essen (CRP apheresis)
Recruiting
- Post-cardiac Surgery
- CRP apheresis
-
Essen, GermanyKlinik für Thorax- und Kardiovaskuläre Chirurgie
Feb 8, 2021
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +4 more
- Cryosurgery
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 3, 2023
Plasma Exchange Trial in Dallas (20-gauge BD Nexiva Diffusics)
Completed
- Plasma Exchange
- 20-gauge BD Nexiva Diffusics
-
Dallas, TexasZale Lipshy Pavilion
May 11, 2022
Covid19 Trial in Germany (CRP-apheresis)
Recruiting
- Covid19
- CRP-apheresis
-
Essen, NRW, Germany
- +3 more
Mar 29, 2022
Hyperlipoproteinemia(a) Trial (Pelacarsen (TQJ230) 80 mg s.c., Corresponding Placebo)
Not yet recruiting
- Hyperlipoproteinemia(a)
- Pelacarsen (TQJ230) 80 mg s.c.
- Corresponding Placebo
- (no location specified)
Mar 22, 2022
Apheresis of Patients With Immunodeficiency
Recruiting
- LAD-1
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)
Terminated
- Decreased Immunologic Activity
- Antibody-mediated Rejection
- Combined apheresis
-
Vienna, AustriaDivision of Medicine III, Dpt. of Nephrology and Dialysis, Medic
Aug 22, 2022
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
National GMA Post-market Clinical Follow-up Study (GRACE)
Recruiting
- Crohn Disease
- Ulcerative Colitis
- Adacolumn
-
Badalona, Barcelona, Spain
- +28 more
Nov 24, 2022
Plasma From People Who Recovered From or Were Vaccinated to
Enrolling by invitation
- Communicable Diseases
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 27, 2022
Diabetes Type 1 Trial in Hackensack (Stem Cell Educator Therapy)
Active, not recruiting
- Diabetes Mellitus Type 1
- Stem Cell Educator Therapy
-
Hackensack, New JerseyHackensack University Medical Center - John Theurer Cancer Cente
Dec 1, 2022
Septic Shock Trial in Calgary (Therapeutic plasma exchange)
Recruiting
- Septic Shock
- Therapeutic plasma exchange
-
Calgary, Alberta, Canada
- +1 more
Feb 15, 2022
Autoimmune Diseases Trial in Braunschweig, Flensburg (Immunoadsorbers GLOBAFFIN® orLIGASORB®)
Recruiting
- Autoimmune Diseases
- Immunoadsorbers GLOBAFFIN® orLIGASORB®
-
Braunschweig, Niedersachsen, Germany
- +1 more
Feb 7, 2022
Septic Shock Trial (Therapeutic Plasma Exchange)
Not yet recruiting
- Septic Shock
- Therapeutic Plasma Exchange
- (no location specified)
Oct 12, 2021
Hematologic Malignancy Trial in Bologna
Recruiting
- Hematologic Malignancy
-
Bologna, ItalyProgramma Dipartimentale Terapie Cellulari Avanzate
Apr 17, 2023
ERT in Pompe Disease: Elucidation of Molecular Structures
Not yet recruiting
- Pompe-Disease
-
Rüsselsheim, Hessen, GermanyCentre for Analytical Biochemistry
Jan 30, 2023
Age-Related Frailty Trial in Santa Monica (Therapeutic Plasma Exchange (TPE))
Enrolling by invitation
- Age-Related Frailty
- Therapeutic Plasma Exchange (TPE)
-
Santa Monica, CaliforniaNeurological Associates - The Interventional Group
Apr 11, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition Trial in Mainz (Immunoadsorption, Sham-apheresis)
Recruiting
- Post-COVID-19 Syndrome
- +2 more
- Immunoadsorption
- Sham-apheresis
-
Mainz, Rheinland-Pfalz, GermanyUNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
May 2, 2023
Ulcerative Colitis Trial in Portugal, Spain (Adacolumn)
Recruiting
- Ulcerative Colitis
- Adacolumn
-
Coimbra, Portugal
- +9 more
Jun 22, 2022